These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19906519)

  • 1. Omega-3 polyunsaturated fatty acids and anxiety disorders.
    Ross BM
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):309-12. PubMed ID: 19906519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids in major depressive disorder.
    Freeman MP
    J Clin Psychiatry; 2009; 70 Suppl 5():7-11. PubMed ID: 19909687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of omega-3 fatty acids in mood disorders.
    Stahl LA; Begg DP; Weisinger RS; Sinclair AJ
    Curr Opin Investig Drugs; 2008 Jan; 9(1):57-64. PubMed ID: 18183532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers.
    Buydens-Branchey L; Branchey M
    J Clin Psychopharmacol; 2006 Dec; 26(6):661-5. PubMed ID: 17110827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism.
    Ross BM
    Med Hypotheses; 2007; 68(3):515-24. PubMed ID: 17045757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation].
    Sempels C; Sienaert P
    Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid facts, Part I. Essential fatty acids as treatment for depression, or food for mood?
    Pawels EK; Volterrani D
    Drug News Perspect; 2008 Oct; 21(8):446-51. PubMed ID: 19034351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anxiety disorders in the Finnish general population.
    Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
    J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acids for major depressive disorder.
    Su KP; Wang SM; Pae CU
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1519-34. PubMed ID: 24083675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence.
    Pouwer F; Nijpels G; Beekman AT; Dekker JM; van Dam RM; Heine RJ; Snoek FJ
    Diabet Med; 2005 Nov; 22(11):1465-75. PubMed ID: 16241908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials.
    Appleton KM; Rogers PJ; Ness AR
    Nutr Res Rev; 2008 Jun; 21(1):13-41. PubMed ID: 19079852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unsaturated fatty acids omega-3. I. Structure, sources, determination, metabolism in the organism].
    Bartnikowska E; Obiedziński MW
    Rocz Panstw Zakl Hig; 1997; 48(4):381-97. PubMed ID: 9562807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
    Popper CW
    J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
    Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
    Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression.
    Su KP
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():151-7. PubMed ID: 18296325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders.
    Serretti A; Chiesa A; Calati R; Perna G; Bellodi L; De Ronchi D
    Int Clin Psychopharmacol; 2009 Jan; 24(1):1-18. PubMed ID: 19060722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?
    Su KP
    Neurosignals; 2009; 17(2):144-52. PubMed ID: 19190401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.